肝切除术后肝衰竭发生的危险因素及防治方法

王才彬; 苏洋

doi:10.3969/j.issn.1001-5256.2020.09.048

肝切除术后肝衰竭发生的危险因素及防治方法

DOI: 10.3969/j.issn.1001-5256.2020.09.048

王才彬,
苏洋

中国医科大学附属盛京医院肝胆脾外科

详细信息

中图分类号: R657.3
计量
- 文章访问数: 1571
- HTML全文浏览量: 43
- PDF下载量: 145
- 被引次数: 0
出版历程
- 出版日期: 2020-09-20

Risk factors for posthepatectomy liver failure and related prevention and treatment methods

Department of Hepatobiliary and Splenic Surgery, Shengjing Hospital of China Medical University

摘要

摘要:
肝切除术是肝脏相关外科手术中较为常见的术式。由于其具有较高的复杂性,肝切除术后的病死率高达30%。而肝切除术后肝衰竭(PHLF)作为术后常见的并发症之一,直接影响接受肝切除术患者术后的无病生存期及总生存期。尽管在近十年来有关肝脏手术的研究与进展有了显著的发展及完善,受到患者术前的一般状态以及肝脏储备功能的影响,PHLF的发生仍然难以避免。虽然如今的技术手段可以明显减少PHLF的病死率并为患者争取到更多的机会,但如何有效的对PHLF的发生进行风险评估,并进一步指导防治策略,仍是肝脏外科医生极为关注的问题。对PHLF的相关研究进行了回顾,包括PHLF的定义、危险因素、术前评估以及PHLF的防治技术手段进展等,为减少PHLF的发生并对其进行有效的干预治疗提供参考。
- 肝切除术 /
- 肝功能衰竭 /
- 危险因素 /
- 治疗学
Abstract:
Hepatectomy is a common surgical procedure for hepatic surgeries,and due to its high complexity,the mortality rate after hepatectomy is as high as 30%. As one of the most common postoperative complications,posthepatectomy liver failure( PHLF) directly affects the disease-free survival and overall survival of patients after hepatectomy. Although there are great improvements in liver surgeries in the past ten years,PHLF cannot be avoided due to the condition and liver reserve function of patients before surgery. Although current techniques can significantly reduce the mortality rate of PHLF and bring more opportunities to patients,how to effectively evaluate the risk of PHLF and guide prevention and treatment strategies is still a major concern of liver surgeons. This article reviews the recent research on PHLF,including the definition,risk factors,preoperative evaluation,and prevention and treatment of PHLF,so as to provide a reference for reducing PHLF and performing effective treatment.
- hepatectomy /
- liver failure /
- risk factors /
- therapeutics

HTML全文

参考文献(54)

[1] CHUANG YH,OU HY,LAZO MZ,et al. Predicting post-hepatectomy liver failure by combined volumetric,functional MR image and laboratory analysis[J]. Liver Int,2018,38(5):868-874.

[2] ZHENG Y,YANG H,HE L,et al. Reassessment of different criteria for diagnosing post-hepatectomy liver failure:A single-center study of 1683 hepatectomy[J]. Oncotarget,2017,8(51):89269-89277.

[3] GILG S,SANDSTRM P,RIZELL M,et al. The impact of posthepatectomy liver failure on mortality:A population-based study[J]. Scand J Gastroenterol,2018,53(10-11):1335-1339.

[4] IGUCHI K,HATANO E,YAMANAKA K,et al. The impact of posthepatectomy liver failure on the recurrence of hepatocellular carcinoma[J]. World J Surg,2014,38(1):150-158.

[5] SCHRECKENBACH T,LIESE J,BECHSTEIN WO,et al. Posthepatectomy liver failure[J]. Dig Surg,2012,29(1):79-85.

[6] BALZAN S,BELGHITI J,FARGES O,et al. The“50-50 criteria”on postoperative day 5:An accurate predictor of liver failure and death after hepatectomy[J]. Ann Surg,2005,242(6):824-828,discussion 828-829.

[7] JIANG BG,ZHOU WP. Early diagnosis and prevention of liver failure after hepatectomy[J/CD]. Chin J Hepat Surg(Electronic Edition),2018,7(5):345-349.(in Chinese)蒋贝格，周伟平．肝切除术后肝衰竭早期诊断及预防[J/CD]．中华肝脏外科手术学电子杂志，2018,7(5):345-349.

[8] MULLEN JT,RIBERO D,REDDY SK,et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy[J]. J Am Coll Surg,2007,204(5):854-862. discussion 862-864.

[9] RAHBARI NN,GARDEN OJ,PADBURY R,et al. Posthepatectomy liver failure:A definition and grading by the International Study Group of Liver Surgery(ISGLS)[J]. Surgery,2011,149(5):713-724.

[10] REISSFELDER C,RAHBARI NN,KOCH M,et al. Postoperative course and clinical significance of biochemical blood tests following hepatic resection[J]. Br J Surg,2011,98(6):836-844.

[11] TIMCHENKO NA. Aging and liver regeneration[J]. Trends Endocrinol Metab,2009,20(4):171-176.

[12] KIM JM,CHO BI,KWON CH,et al. Hepatectomy is a reasonable option for older patients with hepatocellular carcinoma[J]. Am J Surg,2015,209(2):391-397.

[13] KAUFFMANN R,FONG Y. Post-hepatectomy liver failure[J]. Hepatobiliary Surg Nutr,2014,3(5):238-246.

[14] LI Q,WANG Y,MA T,et al. Clinical outcomes of patients with and without diabetes mellitus after hepatectomy:A systematic review and meta-analysis[J]. PLo S One,2017,12(2):e0171129.

[15] LITTLE SA,JARNAGIN WR,DEMATTEO RP,et al. Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer[J]. J Gastrointest Surg,2002,6(1):88-94.

[16] LANGELLA S,RUSSOLILLO N,FORCHINO F,et al. Impact of obesity on postoperative outcome of hepatic resection for colorectal metastases[J]. Surgery,2015,158(6):1521-1529.

[17] OKAMURA Y,MAEDA A,MATSUNAGA K,et al. Negative impact of low body mass index on surgical outcomes after hepatectomy for hepatocellular carcinoma[J]. J Hepatobiliary Pancreat Sci,2012,19(4):449-457.

[18] LISMAN T,LUYENDYK JP. Platelets as modulators of liver diseases[J]. Semin Thromb Hemost,2018,44(2):114-125.

[19] MEHRABI A,GOLRIZ M,KHAJEH E,et al. Meta-analysis of the prognostic role of perioperative platelet count in posthepatectomy liver failure and mortality[J]. Br J Surg,2018,105(10):1254-1261.

[20] RAY S,MEHTA NN,GOLHAR A,et al. Post hepatectomy liver failure-A comprehensive review of current concepts and controversies[J]. Ann Med Surg(Lond),2018,34:4-10.

[21] QADAN M,GARDEN OJ,CORVERA CU,et al. Management of postoperative hepatic failure[J]. J Am Coll Surg,2016,222(2):195-208.

[22] RAHNEMAI-AZAR AA,CLOYD JM,WEBER SM,et al. Update on liver failure following hepatic resection:strategies for prediction and avoidance of post-operative liver insufficiency[J]. J Clin Transl Hepatol,2018,6(1):97-104.

[23] FUKUSHIMA K,FUKUMOTO T,KURAMITSU K,et al. Assessment of ISGLS definition of posthepatectomy liver failure and its effect on outcome in patients with hepatocellular carcinoma[J]. J Gastrointest Surg,2014,18(4):729-736.

[24] REDDY SK,MARSH JW,VARLEY PR,et al. Underlying steatohepatitis,but not simple hepatic steatosis,increases morbidity after liver resection:A case-control study[J].Hepatology,2012,56(6):2221-2230.

[25] IACONO C,RUZZENENTE A,CAMPAGNARO T,et al. Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection:Highlights and drawbacks[J]. Ann Surg,2013,257(2):191-204.

[26] KLOEK JJ,LEVI M,HEGER M,et al. Cholestasis enhances liver ischemia/reperfusion-induced coagulation activation in rats[J]. Hepatol Res,2010,40(2):204-215.

[27] OLTHOF PB,WIGGERS JK,GROOT KOERKAMP B,et al.Postoperative liver failure risk score:identifying patients with resectable perihilar cholangiocarcinoma who can benefit from portal vein embolization[J]. J Am Coll Surg,2017,225(3):387-394.

[28] MANSOUR JC,ALOIA TA,CRANE CH,et al. Hilar cholangiocarcinoma:Expert consensus statement[J]. HPB(Oxford),2015,17(8):691-699.

[29] JIANG L. The problems and discussion on the controversy of preoperative biliary drainage in malignant obstructive jaundice[J]. Med Recapitulate,2014,20(5):806-809.(in Chinese)姜岚．恶性梗阻性黄疸术前减黄相关问题及争议的探讨[J]．医学综述，2014,20(5):806-809.

[30] VAUTHEY JN,PAWLIK TM,RIBERO D,et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases[J]. J Clin Oncol,2006,24(13):2065-2072.

[31] KONG FH,MIAO XY,ZOU H,et al. End-stage liver disease score and future liver remnant volume predict post-hepatectomy liver failure in hepatocellular carcinoma[J]. World J Clin Cases,2019,7(22):3734-3741.

[32] YU HC,YOU H,LEE H,et al. Estimation of standard liver volume for liver transplantation in the Korean population[J]. Liver Transpl,2004,10(6):779-783.

[33] KIM HJ,KIM CY,PARK EK,et al. Volumetric analysis and indocyanine green retention rate at 15 min as predictors of post-hepatectomy liver failure[J]. HPB(Oxford),2015,17(2):159-167.

[34] LIANG J,ARIIZUMI SI,NAKANO M,et al. Diabetes mellitus and/or nonalcoholic steatohepatitis-related hepatocellular carcinoma showed favorable surgical outcomes after hepatectomy[J]. Anticancer Res,2019,39(10):5639-5643.

[35] MAI RY,YE JZ,BAI T,et al. Advances in the prevention and treatment of posthepatectomy liver failure in patients with primary liver cancer[J]. J Clin Hepatol,2018,34(12):2685-2692.(in Chinese)麦荣云，叶甲舟，白涛，等．原发性肝癌肝切除术后肝衰竭的防治进展[J]．临床肝胆病杂志，2018,34(12):2685-2692.

[36] ZHOU M,LI XH,CHANG Q. The predictive value of interleukin-6 for the occurrence of hepatic failure after hepatectomyin patients with hepatocellular carcinoma[J]. Traum Crit Med,2020,8(4):255-258.(in Chinese)周密，李修红，常清．白细胞介素-6对原发性肝细胞癌患者肝切除术后肝衰竭发生预测价值[J]．创伤与急危重病医学，2020,8(4):255-258.

[37] JOHNSON PJ,BERHANE S,KAGEBAYASHI C,et al. Assessment of liver function in patients with hepatocellular carcinoma:A new evidence-based approach-the ALBI grade[J]. J Clin Oncol,2015,33(6):550-558.

[38] ZHOU P,CHEN B,MIAO XY,et al. Comparison of FIB-4 index and child-pugh score in predicting the outcome of hepatic resection for hepatocellular carcinoma[J]. J Gastrointest Surg,2020,24(4):823-831.

[39] NISHIO T,TAURA K,KOYAMA Y,et al. Prediction of posthepatectomy liver failure based on liver stiffness measurement in patients with hepatocellular carcinoma[J]. Surgery,2016,159(2):399-408.

[40] CHEN H,MA JY,QIAN LQ,et al. Value of spleen stiffness and spleen volume in predicting posthepatectomy liver failure in patients with hepatocellular carcinoma[J]. J Clin Hepatol,2019,35(12):2725-2729.(in Chinese)陈皓，马俊永，钱利强，等．脾脏硬度和体积预测肝细胞癌患者肝切除术后发生肝功能衰竭的价值[J]．临床肝胆病杂志，2019,35(12):2725-2729.

[41] LEVESQUE E,MARTIN E,DUDAU D,et al. Current use and perspective of indocyanine green clearance in liver diseases[J]. Anaesth Crit Care Pain Med,2016,35(1):49-57.

[42] IMAMURA H,SANO K,SUGAWARA Y,et al. Assessment of hepatic reserve for indication of hepatic resection:Decision tree incorporating indocyanine green test[J]. J Hepatobiliary Pancreat Surg,2005,12(1):16-22.

[43] YI H,CAI B,AI X,et al. Value of contrast-enhanced ultrasound for preoperative assessment of liver reserve function in patients with liver tumors[J]. PLo S One,2019,14(9):e0222514.

[44] OGATA S,BELGHITI J,FARGES O,et al. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma[J]. Br J Surg,2006,93(9):1091-1098.

[45] D'HAESE JG,NEUMANN J,WENIGER M,et al. Should ALPPS be used for liver resection in intermediate-stage HCC?[J]. Ann Surg Oncol,2016,23(4):1335-1343.

[46] VENNARECCI G,FERRARO D,TUDISCO A,et al. The ALPPS procedure:Hepatocellular carcinoma as a main indication. An Italian single-center experience[J]. Updates Surg,2019,71(1):67-75.

[47] FU S,LI N,ZHOU PC,et al. Detection of HBV DNA and antigens in HBsAg-positive patients with primary hepatocellular carcinoma[J]. Clin Res Hepatol Gastroenterol,2017,41(4):415-423.

[48] LI L,LI B,ZHANG M. HBV DNA levels impact the prognosis of hepatocellular carcinoma patients with microvascular invasion[J]. Medicine(Baltimore),2019,98(27):e16308.

[49] GONG WF,ZHONG JH,LU SD,et al. Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma[J]. Oncotarget,2017,8(9):15047-15056.

[50] VASSILIOU I,ARKADOPOULOS N,STAFYLA V,et al. The introduction of a simple maneuver to reduce the risk of postoperative bleeding after major hepatectomies[J]. J Hepatobiliary Pancreat Surg,2009,16(4):552-556.

[51] KANORIA S,ROBERTSON FP,MEHTA NN,et al. Effect of remote ischaemic preconditioning on liver injury in patients undergoing major hepatectomy for colorectal liver metastasis:A pilot randomised controlled feasibility trial[J]. World J Surg,2017,41(5):1322-1330.

[52] CHAN SC,SHARR WW,CHAN AC,et al. Rescue living-donor liver transplantation for liver failure following hepatectomy for hepatocellular carcinoma[J]. Liver Cancer,2013,2(3-4):332-337.

[53] KOMARDINA E,YAROUSTOVSKY M,ABRAMYAN M,et al.Prometheus therapy for the treatment of acute liver failure in patients after cardiac surgery[J]. Kardiochir Torakochirurgia Pol,2017,14(4):230-235.

[54] HE YT,QI YN,ZHANG BQ,et al. Bioartificial liver support systems for acute liver failure:A systematic review and metaanalysis of the clinical and preclinical literature[J]. World J Gastroenterol,2019,25(27):3634-3648.

施引文献

资源附件(0)

访问统计